In an era of tight budgets, crowdsource fundraising helps advance T1 tech and treatments.
Needle fear gets in the way of insulin therapy. Will Medtronic’s i-port provide relief from being a pincushion?
An inaccurate BG reading can kill. Diabetes researchers and activists are pushing for tighter test strip standards.
Could a T1 rebranding bring scientists closer to a cure?
Dr. Claresa Levetan explains how activating a regenerative gene may be the key for T1s to start producing insulin again.
University of Virginia researchers use an enzyme to reverse neuropathy in mice.
Diabetes advocates in the U.S. have long argued that Europe gets new diabetes treatments first. Is it true?
Researchers have received an NIH grant to develop an AP that can predict insulin levels during physical exertion.
When a diabetes researcher wears a glucose sensor, she is reminded that diabetes is mainly physiological.
Researchers find that most people with T1 diabetes still produce a low level of insulin.
Hypoglycemia is scary enough without the prospect of a silent low. Here’s what you can do about it.
PatientsLikeMe encourages people with diabetes and others with chronic conditions to share their health experiences online.
Researchers find alefacept helps people with T1 diabetes maintain insulin production.
We’ve gotten good at curing diabetes in mice. Where’s the cure for humans?
We all know about bolus, but do you know how basal insulin works? Here’s the inside story.
Glucagon kits can prove too cumbersome in a crisis. Now there’s hope of an easy-to-use glucagon pen on the horizon.
Will the FDA approve inhalable insulin?
Finnish researchers say they’ve found the virus that causes T1 diabetes.
Scientists grow 40,000 pancreatic cells in a week using a 3-D structure.
A new study finds dapagliflozin might help lower A1c levels when insulin alone isn’t cutting it.
Sign up to receive email notifications about new Insulin Nation stories